tm
Seeing Is Believing
tm
Seeing Is Believing
INKT is currently covered by 1 analysts with an average price target of $15.07. This is a potential upside of $2.89 (23.73%) from yesterday's end of day stock price of $12.18.
Mink Therapeutics's activity chart (see below) currently has 18 price targets and 18 ratings on display. The stock rating distribution of INKT is 75% BUY and 25% HOLD.
Analysts average stock forecasts to be materialized ratio is 71.15% with an average time for these price targets to be met of 378 days.
Highest price target for INKT is $35, Lowest price target is $35, average price target is $35.
Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 15-Aug-2025. First documented stock forecast 09-Nov-2021.
Currently out of the existing stock ratings of INKT, 3 are a BUY (75%), 1 are a HOLD (25%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$35
$23.84 (213.62%)
$35
4 months ago
(15-Aug-2025)
11/13 (84.62%)
$20.09 (134.74%)
242
Buy
$4
$-7.16 (-64.16%)
$8
1 years 1 months ago
(15-Nov-2024)
1/2 (50%)
$-3.54 (-46.95%)
506
Buy
$3
$-6.5 (-68.42%)
$30
2 years 8 months 23 days ago
(22-Mar-2023)
1/2 (50%)
$0.91 (43.54%)
92
Buy
$7
$-4.16 (-37.28%)
$10
3 years 7 months 4 days ago
(11-May-2022)
2/2 (100%)
$-5.9 (-45.74%)
672
What is INKT (Mink Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on INKT (Mink Therapeutics) with a proven track record?
Which analyst has the current lower performing score on INKT (Mink Therapeutics) with a proven track record?
Which analyst has the most public recommendations on INKT (Mink Therapeutics)?
Which analyst is the currently most bullish on INKT (Mink Therapeutics)?
Which analyst is the currently most reserved on INKT (Mink Therapeutics)?
